Deals - Frequently asked questions on M&A in Asia

View this page in: 简体中文版
Expand all Collapse all
Please click on the links below to view more:
Why is statutory valuation important when acquiring assets in China?

How do I minimise China M&A Risk during the transaction screening process?

How does the IFRS 3 affect my acquisition in China?

What does SarbOx mean for my M&A deal in China?

What is the function of Tax Due Diligence in M&A?

What valuation methodologies are used to determine a price for a targeted company? Does financial due diligence have an impact on the valuation?

In acquiring a state-owned enterprise in the PRC, an asset-based valuation must be performed by an authorised appraiser. Does financial due diligence still play a part in this type of transaction after the valuation exercise?

How should the areas of potential overlap between legal and financial due diligence be minimised?

What steps are taken in financial due diligence to assist in identifying hidden liabilities and potential exposures?

Will there be a conflict of interest if both the vendor and acquirer appoint the same firm of accountants for due diligence advice?

There is always a conflict between the vendor and the purchase where the vendor is reluctant to provide all information to the purchaser during due diligence as the vendor cannot be certain whether the purchaser will actually go ahead with the acquisition. On the other hand, the purchaser would like to know as much information as possible to evaluate the business. Are there any practical solutions for resolving this kind of conflict, particularly when the potential purchaser is a direct competitor of the vendor?

How do the US Foreign Corrupt Practice Act (FCPA) and Organisation for Economic Co-operation and Development (OECD) anti-corruption regulation impact the ability to do a transaction in China?